Literature DB >> 16391229

Necrotic death as a cell fate.

Wei-Xing Zong1, Craig B Thompson.   

Abstract

Organismal homeostasis depends on an intricate balance between cell death and renewal. Early pathologists recognized that this balance could be disrupted by the extensive damage observed in internal organs during the course of certain diseases. This form of tissue damage was termed "necrosis", derived from the Greek "nekros" for corpse. As it became clear that the essential building block of tissue was the cell, necrosis came to be used to describe pathologic cell death. Until recently, necrotic cell death was believed to result from injuries that caused an irreversible bioenergetic compromise. The cell dying by necrosis has been viewed as a victim of extrinsic events beyond its control. However, recent evidence suggests that a cell can initiate its own demise by necrosis in a manner that initiates both inflammatory and/or reparative responses in the host. By initiating these adaptive responses, programmed cell necrosis may serve to maintain tissue and organismal integrity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391229     DOI: 10.1101/gad.1376506

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  305 in total

1.  zVAD-induced necroptosis in L929 cells depends on autocrine production of TNFα mediated by the PKC-MAPKs-AP-1 pathway.

Authors:  Y-T Wu; H-L Tan; Q Huang; X-J Sun; X Zhu; H-M Shen
Journal:  Cell Death Differ       Date:  2010-06-11       Impact factor: 15.828

2.  PERSISTENT TAPETAL CELL1 encodes a PHD-finger protein that is required for tapetal cell death and pollen development in rice.

Authors:  Hui Li; Zheng Yuan; Gema Vizcay-Barrena; Caiyun Yang; Wanqi Liang; Jie Zong; Zoe A Wilson; Dabing Zhang
Journal:  Plant Physiol       Date:  2011-04-22       Impact factor: 8.340

Review 3.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

4.  p53 opens the mitochondrial permeability transition pore to trigger necrosis.

Authors:  Angelina V Vaseva; Natalie D Marchenko; Kyungmin Ji; Stella E Tsirka; Sonja Holzmann; Ute M Moll
Journal:  Cell       Date:  2012-06-22       Impact factor: 41.582

Review 5.  How do I kill thee? Let me count the ways: p53 regulates PARP-1 dependent necrosis.

Authors:  Rana Elkholi; Jerry E Chipuk
Journal:  Bioessays       Date:  2013-10-24       Impact factor: 4.345

6.  Piper betle leaf extract enhances the cytotoxicity effect of 5-fluorouracil in inhibiting the growth of HT29 and HCT116 colon cancer cells.

Authors:  Pek Leng Ng; Nor Fadilah Rajab; Sue Mian Then; Yasmin Anum Mohd Yusof; Wan Zurinah Wan Ngah; Kar Yong Pin; Mee Lee Looi
Journal:  J Zhejiang Univ Sci B       Date:  2014-08       Impact factor: 3.066

7.  BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy.

Authors:  Kristin Tracy; Benjamin C Dibling; Benjamin T Spike; James R Knabb; Paul Schumacker; Kay F Macleod
Journal:  Mol Cell Biol       Date:  2007-06-18       Impact factor: 4.272

Review 8.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

9.  Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis.

Authors:  Shawn M Jobe; Katina M Wilson; Lorie Leo; Alejandro Raimondi; Jeffery D Molkentin; Steven R Lentz; Jorge Di Paola
Journal:  Blood       Date:  2007-11-07       Impact factor: 22.113

10.  Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis.

Authors:  Rana S Moubarak; Victor J Yuste; Cédric Artus; Aïda Bouharrour; Peter A Greer; Josiane Menissier-de Murcia; Santos A Susin
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.